Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04669574 · ClinicalTrials.gov registry record
Assessing Sleep and Circadian Rhythms in Primary Brain Tumors Patients
A clinical trial, sponsored by National Cancer Institute (NCI).
- Completed
- Registry status
- 101
- Enrollment target
NCT04669574: Completed study, sponsored by National Cancer Institute (NCI).
NCT04669574 is a clinical trial that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 101 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04669574 has completed, sponsored by National Cancer Institute (NCI).
- COMPLETED
- Registry status
- 101 participants
- Enrollment target
Study Summary
Background: Sleep disturbances are among the most common and severe symptoms reported by people with primary brain tumors (PBT). Smart wearable devices like Fitbits may be able to give detailed data about people s sleep and circadian rhythms. In this study, researchers will use Fitbits to learn more about sleep disruptions caused by tumors. This might help them design better future treatment and supportive care studies. Objective: To describe sleep disturbances and circadian disruption in people with PBT. Eligibility: English-speaking adults ages 18 and older who have PBT and are enrolled in the NIH study, Evaluation of the Natural History of and Specimen Banking for Patients with Tumors of the Central Nervous System. It is also known as the Natural History Study, trial #16C0151. Design: Participants will be screened over the telephone or in person. They will be asked about their medical history. Their cancer diagnosis will be confirmed through test results and pathology reports. Participants will complete 4 surveys. The surveys take about 20 minutes to complete and will ask about: The quality of their sleep Their ability to fall asleep and stay asleep How the quality of their sleep affects their daily activities Their sleep hygiene and preferences Participants will get a Fitbit. It looks like a watch and is worn on the wrist. They will connect the device to their smart phone to track sleep, heart rate, and activity. They will wear it for 1 month. Participants will keep a daily sleep diary for 1 week. It will be sent via an electronic link. They will also repeat 2 of the surveys. Participation will last for 1 month.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 101 participants |
| Start Date | 2021-06-29 |
| Est. Completion | 2024-12-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04669574
The ClinicalTrials.gov registry entry for NCT04669574 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 101 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Cancer Institute (NCI), which has 3,257 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT04669574 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04669574 about?
NCT04669574 is a clinical study titled "Assessing Sleep and Circadian Rhythms in Primary Brain Tumors Patients". Background: Sleep disturbances are among the most common and severe symptoms reported by people with primary brain tumors (PBT). Smart wearable devices like Fitbits may be able to give detailed data about people s sleep and circadian rhythms. In this study, researchers will use Fitbits to learn mor...
What is the current status of trial NCT04669574?
This trial is currently completed. The enrollment target is 101 participants. The study started on 2021-06-29. Estimated completion is 2024-12-09.
Who is sponsoring clinical trial NCT04669574?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.